Cristian Massacesi, Executive Vice President, Chief Medical Officer, and Head of Development at Bristol Myers Squibb, filed a Form 4 on September 10, 2026, reporting the sale of 6,249 shares of common stock on September 9, 2026.

Key Highlights

  • Reporting person: Cristian Massacesi, EVP, Chief Medical Officer, Head of Development at Bristol Myers Squibb
  • Transaction: Disposition (code S) of 6,249 shares of Common Stock, $0.10 par value, on September 9, 2026
  • Sale price: $64.57 per share
  • Remaining holdings: 18,748 shares of Common Stock held directly following the transaction
  • Filing date: September 10, 2026, signed by Amy Fallone as attorney-in-fact for Cristian Massacesi

Massacesi Share Sale Details: Bristol Myers Squibb Form 4

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Cristian Massacesi, who serves as Executive Vice President, Chief Medical Officer, and Head of Development at Bristol Myers Squibb (NYSE:BMY), disposed of 6,249 shares of the company's Common Stock, $0.10 par value, on September 9, 2026. The transaction was coded "S," indicating an open-market sale, at a price of $64.57 per share.

The filing reports that following this transaction, Massacesi directly owns 18,748 shares of Bristol Myers Squibb Common Stock. No derivative securities transactions were reported in Table II of the filing. The form was filed by one reporting person and covers a single transaction date of September 9, 2026, which is also listed as the date of the earliest transaction.

The Form 4 was signed on September 10, 2026, by Amy Fallone as attorney-in-fact for Cristian Massacesi. No explanation of responses or additional remarks were included in the filing.

What Was Disclosed

The filing discloses a single open-market sale of 6,249 shares of Bristol Myers Squibb Common Stock at $64.57 per share by EVP and Chief Medical Officer Cristian Massacesi on September 9, 2026, leaving him with 18,748 directly held shares.